Trajan Scientific and Medical “Trajan” today announced the acquisition of the business of LEAP Technologies (NC, USA).
Formed in 1989 Carrboro, NC in order to serve the automation needs of analytical laboratories (Chromatography and Mass Spectrometry related), LEAP delivers solutions in the fields of research and development, life science, pharmaceutical, polymer, food processing, forensic, and academia.
Bringing LEAP into the Trajan Group will complement the widening capability of Trajan, servicing their vision to make a positive impact on human wellbeing. It will improve science and laboratory workflows to ultimately bring testing of the sample closer to the source, while supporting improved efficiencies in the lab.
Chief Executive Officer of Trajan, Mr Stephen Tomisich, comments: “We are so pleased to welcome the LEAP team into the Trajan family. Trajan has a technology-rich development pipeline of disruptive sampling and sample preparation products speeding towards commercialization and LEAP provides the automation capability to allow adoption into laboratory workflows. We think it’s a partnership with huge potential!”
Werner Martin, President of LEAP Technologies predicts: “The opportunity for LEAP to join Trajan will be a tremendous step forward to best apply new automation configurations for the fast evolving analytical chemistry laboratories worldwide. The synergies are multiple and can speed up the positive impact on human wellbeing by improving developments for laboratory automation and workflow.”
Mr Sal Iacono, LEAP Technologies CEO echoes this sentiment: “LEAP's team is very pleased about becoming part of the Trajan organization! In particular, the expanded opportunities to generate more disruptive, efficient and streamlined solutions such as LEAP's innovative HDX platform, for the life science, environmental and diagnostic markets is immensely exciting. We are eagerly looking forward to continuing and further expanding our relationships with superb technology partners such as CTC Analytics, Axel-Semrau and Gyger to name a few, in integrating their outstanding offerings with Trajan's many disruptive technologies to provide superior innovation to the marketplace.”
Press Release [PDF]
Media Contact Information
Trajan Scientific and Medical
+44 (0) 1244403100
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.